Accueil   Agenda - News   Toutes les news BIOTEM enters into collaboration with CALIXAR for the development of therapeutic antibodies against membrane targets

BIOTEM enters into collaboration with CALIXAR for the development of therapeutic antibodies against membrane targets

 

Apprieu, May 20, 2019 – BIOTEM, a key player in the development of monoclonal antibodies of excellence, is pleased to announce the launch of a collaboration with CALIXAR, an innovative company specialized in the isolation and production of native and functional membrane proteins (MP).

 


Together, the two companies continue their commitment to develop future immunotherapies. Combining complementary skills and know-how, the BIOTEM-CALIXAR partnership aims to provide new therapeutic antibodies against challenging antigens of high medical relevance. This specific approach will increase chances to succeed in clinical stages.

 

Read the press release

En poursuivant votre navigation sur ce site, vous acceptez l'utilisation de cookies pour vous proposer des services et offres adaptés à vos centres d'intérêt. En savoir plus... Fermer